European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging—measured disease activity and burden in patients with relapsing multiple sclerosis - Comi, G; Filippi, M; Wolinsky, J SEuropean/Canadian Glatiramer Acetate Study Group (Ann Neurol, 2001)